Clinical Professor at Hwasun Chonnam National University Hospital Selected for Research Funding by the Korean Society of Cardiovascular Interventions
[Asia Economy Honam Reporting Headquarters Reporter Lee Gwan-woo] The research project of Hyun Dae-yong, clinical professor of cardiology at Hwasun Chonnam National University Hospital, was recently selected for academic research funding by the Korean Society of Cardiovascular Interventions.
According to Hwasun Chonnam National University Hospital on the 6th, the Korean Society of Cardiovascular Interventions selected clinical professor Hyun Dae-yong’s research project titled “Development of a Superabsorbent Polymer Nanofiber/Stent Composite to Prevent Restenosis” for the 14th academic research projects of the Korean Society of Cardiovascular Interventions in 2020.
In particular, among the research projects that underwent rigorous review, this project ranked first in new researcher funding.
Accordingly, research professor Hyun will collaborate with Professor Yoon Myung-han’s team at Gwangju Institute of Science and Technology to fabricate a nanofiber/stent composite using superabsorbent polymers and evaluate its safety and efficacy through preclinical pig animal experiments.
This research is expected to serve as a foundation for developing a new stent that minimizes the problems of restenosis and thrombosis associated with currently used stents.
Hot Picks Today
"Samsung and Hynix Were Once for the Underachievers"... Hyundai Motor Employee's Lament
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- After Losing Her Only Daughter, a Mother in China Gave Birth to Twins at 60... Reinventing Life at 76
- KOSPI Drops Over 3% Intraday, Falls Below 7,300 Mark
- "That? It's Already Stashed" Nightlife Scene Crosses the Line [ChwiYak Nation] ③
Clinical professor Hyun previously received the Excellent Paper Award from the Korean Society of Internal Medicine for his paper titled “Two-Year Clinical Outcomes of Stable Angina and Acute Coronary Syndrome Patients after Left Main Coronary Artery Intervention,” and has continuously participated in pig experiments for the development of the biopolymer-free drug-eluting stent Tiger Revolution, receiving a commendation for 3,000 cases of cardiac catheterization experiments.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.